AUPH

Aurinia Pharmaceuticals Stock Analysis

AI Rating

Good
  • Quality5/10
  • Growth↑ 9/10
  • Value↓ 3/10
Aurinia Pharmaceuticals sales and earnings growth
AUPH Growth
Great
  • Revenue Y/Y↑ 20.38%
  • EPS Y/Y↑ 5250.00%
  • FCF Y/Y↑ 206.99%
Aurinia Pharmaceuticals gross and profit margin trends
AUPH Profitability
Great
  • Gross margin ↑ 88.50%
  • EPS margin↑ 101.50%
  • ROIC 5Y↑ -2.92%
Aurinia Pharmaceuticals net debt vs free cash flow
AUPH Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 27.4

Aurinia Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗